Cibus, Inc. (NASDAQ:CBUS - Free Report) - HC Wainwright lowered their FY2029 earnings estimates for shares of Cibus in a research note issued on Friday, August 14th. HC Wainwright analyst A. Dayal now anticipates that the company will post earnings of $0.27 per share for the year, down from their prior forecast of $0.28. The consensus estimate for Cibus' current full-year earnings is ($1.05) per share. HC Wainwright also issued estimates for Cibus' FY2030 earnings at $2.08 EPS.
Cibus (NASDAQ:CBUS - Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.10). The business had revenue of $0.99 million during the quarter, compared to analysts' expectations of $1.70 million. Cibus had a negative return on equity of 287.03% and a negative net margin of 2,258.89%.
Several other analysts have also recently weighed in on CBUS. Wall Street Zen raised Cibus from a "sell" rating to a "hold" rating in a report on Saturday, July 25th. Weiss Ratings cut shares of Cibus from a "sell (d-)" rating to a "sell (e+)" rating in a research report on Monday, June 29th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $9.00.
Get Our Latest Stock Report on Cibus
Cibus Price Performance
Cibus stock opened at $1.77 on Monday. Cibus has a 52 week low of $1.09 and a 52 week high of $4.19. The business has a 50-day simple moving average of $1.65 and a 200 day simple moving average of $1.97. The stock has a market cap of $135.10 million, a price-to-earnings ratio of -1.07 and a beta of 1.61.
Institutional Investors Weigh In On Cibus
Large investors have recently added to or reduced their stakes in the company. PACK Private Wealth LLC bought a new position in shares of Cibus during the 4th quarter valued at about $27,000. Dimensional Fund Advisors LP bought a new stake in Cibus in the 1st quarter worth approximately $33,000. Qube Research & Technologies Ltd purchased a new stake in Cibus in the second quarter worth approximately $39,000. Rockland Trust Co. purchased a new stake in Cibus in the second quarter worth approximately $41,000. Finally, Squarepoint Ops LLC bought a new position in Cibus during the third quarter valued at approximately $62,000. Hedge funds and other institutional investors own 33.81% of the company's stock.
About Cibus
(
Get Free Report)
Cibus, Inc is a biotechnology company specializing in precision gene editing for agricultural applications. Leveraging its proprietary Rapid Trait Development System (RTDS), Cibus develops improved crop traits without the introduction of foreign DNA. The company's platform enables targeted modifications to plant genomes, allowing for enhanced disease resistance, herbicide tolerance and yield optimization in key row crops.
The company's core business centers on trait development services and licensing partnerships.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Cibus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cibus wasn't on the list.
While Cibus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
